Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRAMEF10 Activators

PRAMEF10 activators represent a diverse chemical class characterized by their ability to modulate gene expression through various epigenetic mechanisms. These activators can influence the cellular machinery responsible for the addition or removal of specific chemical groups, such as methyl or acetyl groups, on DNA and histone proteins, which in turn can alter the expression of PRAMEF10. This class includes inhibitors of DNA methyltransferases and histone deacetylases, among other enzyme targets. By inhibiting DNA methyltransferases, PRAMEF10 activators can promote the demethylation of DNA, which typically leads to a more open chromatin state and increased gene transcription. On the other hand, by inhibiting histone deacetylases, these activators can increase the acetylation levels of histones, also leading to an open chromatin configuration conducive to gene expression.

The chemical agents classified as PRAMEF10 activators can also engage with cellular signaling pathways that govern gene expression. They can interact with receptors that transduce signals to initiate transcription, thereby impacting the expression of a wide range of genes, including those that may be otherwise silent or expressed at low levels. Importantly, the activators in this class function at the molecular level to influence the epigenetic landscape of cells, which can result in changes to the transcriptional activity of genes like PRAMEF10. This modulation of gene expression is a fundamental process in cellular function and can have wide-ranging effects on the phenotype of a cell. Through such intricate molecular interactions, PRAMEF10 activators can play a significant role in the dynamic regulation of gene expression without altering the underlying DNA sequence.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A DNA methyltransferase inhibitor that could activate PRAMEF10 by leading to the demethylation and activation of gene expression, including genes that may be epigenetically silenced.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor that could activate PRAMEF10 by causing chromatin to become more accessible for transcription, potentially increasing the expression of genes.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

An aldehyde dehydrogenase inhibitor, which has been shown to modulate epigenetic regulation and could activate PRAMEF10 by influencing the expression of proteins.

6-Thioguanine

154-42-7sc-205587
sc-205587A
250 mg
500 mg
$42.00
$54.00
3
(1)

A histone deacetylase inhibitor that could activate PRAMEF10 by leading to hyperacetylation of histones, potentially affecting gene expression patterns.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

A metabolite of vitamin A that regulates gene expression through retinoid receptors and could activate PRAMEF10 by affecting the expression of related proteins.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

A short-chain fatty acid and histone deacetylase inhibitor that could activate PRAMEF10 by altering gene expression.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

A polyphenolic compound that could activate PRAMEF10 by modulating multiple cellular pathways through its effects on gene expression.

Tazarotene

118292-40-3sc-220193
10 mg
$103.00
(0)

A synthetic retinoid that could activate PRAMEF10 by affecting gene expression through retinoid receptors.